Construction Plan and time line for The Manufacturing Facilities

  • 1st Plant: Dedicated for Insulin, Insulin Analogs, and other Biosimilars (mAbs)

    Insulin, Insulin Glargine, Insulin Lispro, Adalimumab, Bevacizumab

    Area

    Land

    Construction Completion Schedule /

  • 2nd Plant: Dedicated for Injectable drugs

    General Injectables (Liquid; SVP, LVP, Lyophilized)

    Area

    Land

    Construction Completion Schedule /

  • Morgantown, West Virginia, USA.

    Dedicated Facility for Insulin & Insulin Analogs

    Insulin & Insulin Analogs

    Area

    Land 23 Acres
    Building -

    Construction Completion Schedule /